Andrew O'Neil

Andrew O'Neil has extensive experience in the pharmaceutical industry, currently serving as a Biosimilar Account Executive at Organon since April 2022. Previously, Andrew held the position of Director of Health System Strategic Accounts West at Indivior, where responsibilities included driving access and growth for the Indivior portfolio within organized health systems. Andrew's career at Merck spanned nearly a decade, during which roles included Subacute Account Executive, Associate Director for Institutional Sales, Senior Specialist in Learning and Development, and Hospital Sales Representative. Andrew holds a Master of Science in Exercise Physiology from the University of Nevada-Las Vegas and a Bachelor of Arts in Education and Sports Medicine from the University of Vermont.